Formula A1 Lipid Amines for Cell-Permeable Payload Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The delivery of biologically active payloads, such as nucleic acids and proteins, to cells is hindered by instability and low cell permeability, necessitating improved lipid nanoparticle compositions for safer and more effective targeted delivery.
Innovation Solution
Development of lipid amine compounds, as depicted by Formula A1, which are incorporated into lipid nanoparticle compositions, along with other lipids, to enhance delivery efficacy and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional lipid nanoparticles are used for payload delivery, then delivery capability is achieved, but safety and specificity are insufficient
Solution Approach 1:
The patent modifies the chemical structure of lipid nanoparticles by incorporating specific amino acid sequences (Formula A1) with defined molecular weight ranges (500-5000 Da) and hydrophobicity parameters. These parameter changes enable the lipid nanoparticles to achieve both effective delivery and improved safety profiles by optimizing the balance between membrane permeability and biological compatibility.
Solution Approach 2:
The invention creates composite lipid nanoparticle formulations by combining the specially designed lipid amine compounds (Formula A1) with other lipid components. This composite approach allows the system to leverage the beneficial properties of each component: the Formula A1 lipids provide targeted delivery and safety, while additional lipid components enhance structural stability and payload encapsulation.
2Reliability
If nucleic acids are delivered to cells, then therapeutic effect is achieved, but cell permeability is low
Solution Approach 1:
The lipid amine compounds of Formula A1 serve as intermediary carriers that facilitate the transport of nucleic acid payloads across cell membranes. These lipid intermediaries bridge the gap between the hydrophilic nucleic acids and the hydrophobic cell membrane, enabling efficient permeation through amphiphilic interactions and membrane integration.
Solution Approach 2:
The patent optimizes the hydrophobicity parameter of the lipid nanoparticles by selecting specific amino acid compositions and molecular weights for Formula A1. This parameter adjustment enhances the ability of the nanoparticle to interact with and penetrate through cell membranes, thereby improving cell permeability while maintaining nucleic acid stability.
3Ease of operation
If lipid nanoparticle composition is optimized for delivery, then permeability improves, but stability may be compromised
Solution Approach 1:
The invention develops composite lipid nanoparticle systems where Formula A1 lipid amine compounds work synergistically with additional lipid components. This composite structure allows the system to achieve both high cell permeability and payload stability, as different lipid components can be selected to provide specific functions: some components enhance membrane interaction while others provide structural stability and protect the payload.
Solution Approach 2:
The patent applies local quality by creating regions of different properties within the lipid nanoparticle structure. The Formula A1 lipids provide cationic charges and hydrophobicity for membrane interaction in specific regions, while other lipid components provide structural stability in different regions. This spatial differentiation of functional properties enables simultaneous optimization of permeability and stability.
Data Source
AI summary
The present invention relates to lipid amine compounds of formula (A1) which are useful in the preparation of lipid nanoparticle compositions for delivery of therapeutic or prophylactic payload into cells.